Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Front Med (Lausanne) ; 10: 1138644, 2023.
Article in English | MEDLINE | ID: mdl-37077670

ABSTRACT

Metabolic causes such as altered bioenergetics and amino acid metabolism may play a major role in Long COVID. Renal-metabolic regulation is an integral part of these pathways but has not been systematically or routinely investigated in Long COVID. Here we discuss the biochemistry of renal tubular injury as it may contribute to Long COVID symptoms. We propose three potential mechanisms that could be involved in Long COVID namely creatine phosphate metabolism, un-reclaimed glomerular filtrate and COVID specific proximal tubule cells (PTC) injury-a tryptophan paradigm. This approach is intended to allow for improved diagnostics and therapy for the long-haul sufferers.

2.
Biomedicines ; 12(1)2023 Dec 28.
Article in English | MEDLINE | ID: mdl-38255181

ABSTRACT

Myoendothelial junctions (MEJs) are structures that allow chemical signals to be transmitted between endothelial cells (ECs) and vascular smooth muscle cells, which control vascular tone. MEJs contain hemoglobin alpha (Hbα) and endothelial nitric oxide synthase (eNOS) complexes that appear to control the production and scavenging of nitric oxide (NO) along with the activity of cytochrome b5 reductase 3 (CYB5R3). The aim of this study was to examine how hypoxia affected the regulation of proteins involved in the production of NO in brain ECs. In brief, human brain microvascular endothelial cells (HBMEC) were exposed to cobalt chloride (CoCl2), a hypoxia mimetic, and a transcriptional analysis was performed using primers for eNOS, CYB5R3, and Hbα2 with ΔΔCt relative gene expression normalized to GAPDH. NO production was also measured after treatment using 4,5-diaminofluorescein diacetate (DAF-DA), a fluorescent NO indicator. When HBMEC were exposed to CoCl2 for 48 h, eNOS and CYB5R3 messenger RNA significantly decreased (up to -17.8 ± 4.30-fold and -10.4 ± 2.8, respectively) while Hbα2 increased to detectable levels. Furthermore, CoCl2 treatment caused a redistribution of peripheral membrane-generated NO production to a perinuclear region. To the best of our knowledge, this is the first time this axis has been studied in brain ECs and these findings imply that hypoxia may cause dysregulation of proteins that regulate NO production in brain MEJs.

3.
Scand J Trauma Resusc Emerg Med ; 23: 98, 2015 Nov 11.
Article in English | MEDLINE | ID: mdl-26561391

ABSTRACT

Electrolyte imbalances are common among patients with traumatic brain injury (TBI). Cerebral salt wasting (CSW) is an electrolyte imbalance characterized by hyponatremia and hypovolemia. Differentiating the syndrome of inappropriate antidiuretic hormone and CSW remains difficult and the pathophysiological mechanisms underlying CSW are unclear. Our intent was to review the literature on CSW within the TBI population, in order to report the incidence and timing of CSW after TBI, examine outcomes, and summarize the biochemical changes in patients who developed CSW. We searched MEDLINE through 2014, hand-reviewed citations, and searched abstracts from the American Association for the Surgery of Trauma (2003-2014). Publications were included if they were conducted within a TBI population, presented original data, and diagnosed CSW. Publications were excluded if they were review articles, discussed hyponatremia but did not differentiate the etiology causing hyponatremia, or presented cases with chronic disease. Fifteen of the 47 publications reviewed met the selection criteria; nine (60%) were case reports, five (33%) were prospective and 1 (7%) was a retrospective study. Incidence of CSW varied between 0.8 - 34.6%. The populations studied were heterogeneous and the criteria used to define hyponatremia and CSW varied. Though believed to play a role in the development of CSW, increased levels of natriuretic peptides in patients diagnosed with CSW were not consistently reported. These findings reinforce the elusiveness of the CSW diagnosis and the need for strict and consistent diagnostic criteria.


Subject(s)
Brain Injuries/complications , Brain Injuries/diagnosis , Hyponatremia/etiology , Hypovolemia/etiology , Brain Injuries/mortality , Female , Glasgow Coma Scale , Humans , Hyponatremia/physiopathology , Hypovolemia/physiopathology , Injury Severity Score , Male , Prognosis , Risk Assessment , Survival Rate , Water-Electrolyte Imbalance/etiology , Water-Electrolyte Imbalance/mortality , Water-Electrolyte Imbalance/physiopathology
5.
J Spinal Cord Med ; 33(1): 65-7, 2010.
Article in English | MEDLINE | ID: mdl-20397445

ABSTRACT

BACKGROUND/OBJECTIVE: To report successful use of a modified protocol of vasopressin receptor antagonist for effective and safe treatment of hyponatremia in a complexly ill patient in the neurorehabilitation setting. DESIGN: Case report. PARTICIPANTS/METHODS: A 57-year-old man with tetraparesis and protracted hyponatremia resistant to standard therapies. RESULTS: This patient's rehabilitation from epidural abscess-induced tetraplegia was complicated by symptomatic hyponatremia. The pathophysiology was multifactorial. The course was prolonged, and several therapeutic endeavors failed. Intravenous infusions of vasopressin receptor antagonist induced and maintained eunatremia. The pace of the patient's recovery improved, and he was discharged with substantial neurologic recovery. No central nervous system toxicities of the treatments were observed. CONCLUSION: Intravenous vasopressin receptor antagonist is an effective and safe treatment for hyponatremia in the rehabilitation setting if the dosage and monitoring protocols are modified in accordance with the physiology of the patient with spinal cord injury.


Subject(s)
Antidiuretic Hormone Receptor Antagonists , Benzazepines/therapeutic use , Hyponatremia/drug therapy , Quadriplegia/drug therapy , Substance Abuse Treatment Centers , Humans , Hyponatremia/complications , Male , Middle Aged , Quadriplegia/complications
7.
Clin Chim Acta ; 378(1-2): 216-8, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17196573

ABSTRACT

INTRODUCTION: Purple urinary bag syndrome (PUBS) is considered to be a benign condition observed in the urinary catheter and bag in some catheterized patients with urinary tract infections. This syndrome is usually reported to occur in alkaline urine. CASE REPORT: We report of a catheterized patient with PUBS and slightly acidic urine (pH 6-6.5). A novel analysis method was developed using high pressure liquid chromatography and mass spectrometry (HPLC/MS) to detect compounds that are thought to be associated with PUBS. Urine, urinary sediment, and the plastic collection system were assayed and quantitated using these methods. The potential toxicity of one of these compounds, indoxyl sulfate, is discussed. CONCLUSIONS: The presence of PUBS in a catheterized patient with slightly acidic urine is reported. A novel method for the analysis of chemical components of PUBS and the first direct confirmation of the presence of indigo in the urine sediment and collecting system are described.


Subject(s)
Indican/urine , Tryptophan/metabolism , Urinary Catheterization/adverse effects , Urinary Tract Infections/urine , Aged , Chromatography, High Pressure Liquid , Female , Humans , Hydrogen-Ion Concentration , Indigo Carmine , Indoles/urine , Mass Spectrometry , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...